E. Verger

3.0k total citations
48 papers, 1.9k citations indexed

About

E. Verger is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, E. Verger has authored 48 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 21 papers in Genetics and 18 papers in Oncology. Recurrent topics in E. Verger's work include Glioma Diagnosis and Treatment (21 papers), Brain Metastases and Treatment (18 papers) and Head and Neck Cancer Studies (8 papers). E. Verger is often cited by papers focused on Glioma Diagnosis and Treatment (21 papers), Brain Metastases and Treatment (18 papers) and Head and Neck Cancer Studies (8 papers). E. Verger collaborates with scholars based in Spain, United Kingdom and Palestinian Territory. E. Verger's co-authors include C. Conill, Manuel Salamero, Francesc Graus, S. Villà, Núria Viñolas, Teresa Pujol, Teresa Ribalta, Manel Salamero, Armando López‐Guillermo and E.M. Bessell and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

E. Verger

46 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Verger Spain 20 750 648 629 288 276 48 1.9k
Brigitte Trétarre France 29 408 0.5× 527 0.8× 972 1.5× 195 0.7× 385 1.4× 122 2.5k
Angela Chetrit Israel 20 419 0.6× 249 0.4× 446 0.7× 232 0.8× 187 0.7× 31 2.6k
May Lin Tao United States 16 441 0.6× 280 0.4× 386 0.6× 187 0.6× 193 0.7× 28 1.4k
A. H. Zwinderman Netherlands 26 352 0.5× 832 1.3× 253 0.4× 111 0.4× 433 1.6× 48 4.0k
Bjørn Henning Grønberg Norway 27 867 1.2× 1.3k 2.0× 1.2k 1.9× 134 0.5× 245 0.9× 111 3.1k
Johan Menten Belgium 32 1.6k 2.2× 1.0k 1.6× 359 0.6× 452 1.6× 237 0.9× 100 3.7k
John Hanson Canada 19 214 0.3× 272 0.4× 676 1.1× 127 0.4× 192 0.7× 36 1.6k
Timothy J. Moynihan United States 22 238 0.3× 703 1.1× 829 1.3× 95 0.3× 471 1.7× 56 1.9k
M.L.L. Prevoo Netherlands 7 890 1.2× 218 0.3× 436 0.7× 178 0.6× 302 1.1× 10 7.0k
H. H. Kuper Netherlands 14 756 1.0× 192 0.3× 358 0.6× 155 0.5× 283 1.0× 16 6.0k

Countries citing papers authored by E. Verger

Since Specialization
Citations

This map shows the geographic impact of E. Verger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Verger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Verger more than expected).

Fields of papers citing papers by E. Verger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Verger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Verger. The network helps show where E. Verger may publish in the future.

Co-authorship network of co-authors of E. Verger

This figure shows the co-authorship network connecting the top 25 collaborators of E. Verger. A scholar is included among the top collaborators of E. Verger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Verger. E. Verger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Martinez‐García, Maria, Estela Pineda, Sonia Del Barco, et al.. (2016). Feasibility and efficacy of concomitant chemoradiation (Ch-RT) in the management of newly diagnosed elderly glioblastoma (GB) patients: Results from the GLIOCAT study.. Journal of Clinical Oncology. 34(15_suppl). 2045–2045.
3.
Muñoz, Carmen, et al.. (2015). Influence of allelic variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer treated with radiotherapy plus cetuximab. European Archives of Oto-Rhino-Laryngology. 273(8). 2193–2199. 3 indexed citations
4.
Aranda, Gloria, Joaquim Enseñat, Mireia Mora, et al.. (2014). Long-term remission and recurrence rate in a cohort of Cushing’s disease: the need for long-term follow-up. Pituitary. 18(1). 142–149. 74 indexed citations
5.
Balañá, Carmen, Miguel Gil‐Gil, Gaspar Reynés, et al.. (2014). Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a Phase II study. Targeted Oncology. 9(4). 321–329. 35 indexed citations
6.
Valduvieco, Izaskun, E. Verger, Jordi Bruna, et al.. (2012). Impact of radiotherapy delay on survival in glioblastoma. Clinical & Translational Oncology. 15(4). 278–282. 48 indexed citations
7.
Simó, Marta, Roser Velasco, Francesc Graus, et al.. (2012). Impact of antiepileptic drugs on thrombocytopenia in glioblastoma patients treated with standard chemoradiotherapy. Journal of Neuro-Oncology. 108(3). 451–458. 26 indexed citations
8.
Verger, E., Izaskun Valduvieco, Teresa Pujol, et al.. (2011). Does gender matter in glioblastoma?. Clinical & Translational Oncology. 13(10). 737–741. 7 indexed citations
9.
Grau, Juan J., Miguel Caballero, E. Verger, Mariano Monzó, & José Luís Blanch. (2009). Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients. Acta Oto-Laryngologica. 129(11). 1294–1299. 43 indexed citations
10.
Conill, C., et al.. (2007). Low dose rate brachytherapy in lip carcinoma. Clinical & Translational Oncology. 9(4). 251–254. 25 indexed citations
11.
Bessell, E.M., Francesc Graus, Armando López‐Guillermo, et al.. (2004). Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. International Journal of Radiation Oncology*Biology*Physics. 59(2). 501–508. 80 indexed citations
12.
Tortosa, Avelina, Núria Viñolas, S. Villà, et al.. (2003). Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas. Cancer. 97(4). 1063–1071. 126 indexed citations
13.
Viñolas, Núria, et al.. (2002). Pre-irradiation semi-intensive chemotherapy with carboplatin and cyclophosphamide in malignant glioma: a phase II study. Anti-Cancer Drugs. 13(2). 163–167. 18 indexed citations
14.
15.
Villà, S., Núria Viñolas, E. Verger, et al.. (1998). Efficacy of radiotherapy for malignant gliomas in elderly patients. International Journal of Radiation Oncology*Biology*Physics. 42(5). 977–980. 54 indexed citations
16.
Conill, C., et al.. (1997). Symptom prevalence in the last week of life. Journal of Pain and Symptom Management. 14(6). 328–331. 148 indexed citations
17.
Conill, C., Julio Astudillo, & E. Verger. (1993). Prognostic significance of metastases to mediastinal lymph node levels in resected non-small cell lung carcinoma. Cancer. 72(4). 1199–1202. 13 indexed citations
18.
Verger, E., Manel Salamero, & C. Conill. (1992). Can Karnofsky performance status be transformed to the Eastern Cooperative Oncology Group scoring scale and vice versa?. European Journal of Cancer. 28(8-9). 1328–1330. 114 indexed citations
19.
Conill, Carles, et al.. (1991). Effects of single dose irradiation on pancreatic beta-cell function. Radiotherapy and Oncology. 22(2). 143–144. 13 indexed citations
20.
Conill, C., E. Verger, & Manuel Salamero. (1990). Performance status assessment in cancer patients. Cancer. 65(8). 1864–1866. 288 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brigitte Trétarre Breakdown of academic impact, for papers by Angela Chetrit Breakdown of academic impact, for papers by May Lin Tao Breakdown of academic impact, for papers by A. H. Zwinderman Breakdown of academic impact, for papers by Bjørn Henning Grønberg Breakdown of academic impact, for papers by Johan Menten Breakdown of academic impact, for papers by John Hanson Breakdown of academic impact, for papers by Timothy J. Moynihan Breakdown of academic impact, for papers by M.L.L. Prevoo Breakdown of academic impact, for papers by H. H. Kuper
Rankless by CCL
2026